Director Robert J. Ciaruffoli filed a Form 4 with the SEC on November 17, 2026, disclosing the acquisition of 72,674 common shares of Medicus Pharma Ltd. (NASDAQ:MDCX) on November 13, 2026, through a private placement subscription agreement.

Key Highlights

  • Reporting person: Robert J. Ciaruffoli, identified as a Director of Medicus Pharma Ltd.
  • Shares acquired: 72,674 common shares, no par value, with transaction code "A" (acquired).
  • Purchase price: $1.72 per share, via a private placement subscription agreement dated November 13, 2026.
  • Post-transaction ownership: Ciaruffoli directly beneficially owned 72,924 common shares following the transaction.
  • Transaction structure: According to the filing, other investors also participated in the same private placement under separate subscription agreements.
  • Filing signed: Raza Bokhari signed as Attorney-in-Fact for Robert J. Ciaruffoli on November 17, 2026.

Ciaruffoli's Private Placement Purchase of Medicus Pharma Common Shares

According to the Form 4 filed with the SEC, Robert J. Ciaruffoli, a director of Medicus Pharma Ltd. (NASDAQ:MDCX), entered into a subscription agreement with the issuer on November 13, 2026. Under that agreement, the filing discloses, Ciaruffoli agreed to purchase 72,674 common shares, no par value, at a purchase price of $1.72 per share in a private placement transaction.

The filing notes that "other investors also participated" in the same private placement "under separate subscription agreements," indicating the transaction was part of a broader capital-raising event. The transaction is recorded in Table I of the Form 4 as a direct acquisition (transaction code "A"), with no derivative securities reported in Table II.

Following the reported transaction, Ciaruffoli's direct beneficial ownership of Medicus Pharma common shares stood at 72,924 shares, according to the filing. The form was filed on November 17, 2026, and signed by Raza Bokhari as Attorney-in-Fact for the reporting person. No amendment date is indicated, and the form was filed by one reporting person.

What Was Disclosed

The filing reports a single acquisition by Director Robert J. Ciaruffoli of 72,674 Medicus Pharma common shares at $1.72 per share on November 13, 2026, through a private placement, bringing his direct beneficial ownership to 72,924 shares.